Corsi, Domenico Cristiano
 Distribuzione geografica
Continente #
NA - Nord America 171
EU - Europa 110
AS - Asia 70
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 362
Nazione #
US - Stati Uniti d'America 171
SE - Svezia 38
SG - Singapore 35
IT - Italia 20
CN - Cina 18
IE - Irlanda 11
DE - Germania 9
ID - Indonesia 8
FR - Francia 7
CI - Costa d'Avorio 6
BE - Belgio 4
HK - Hong Kong 4
LU - Lussemburgo 4
RU - Federazione Russa 4
A2 - ???statistics.table.value.countryCode.A2??? 2
FI - Finlandia 2
GB - Regno Unito 2
JP - Giappone 2
LT - Lituania 2
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
KR - Corea 1
LV - Lettonia 1
NL - Olanda 1
NO - Norvegia 1
SC - Seychelles 1
TR - Turchia 1
VN - Vietnam 1
Totale 362
Città #
Chandler 57
Singapore 31
Dublin 11
Ashburn 9
San Mateo 9
Jakarta 8
Abidjan 6
Ann Arbor 6
Bremen 6
Marseille 6
Princeton 6
Boston 5
Houston 5
Brussels 4
Fairfield 4
Hangzhou 4
Montepulciano 4
New York 4
Redwood City 4
Wilmington 4
Andover 3
Guangzhou 3
Jacksonville 3
Moscow 3
Rome 3
Cattolica 2
Dearborn 2
Formia 2
Helsinki 2
Hong Kong 2
Nanjing 2
Seattle 2
Tianjin 2
Woodbridge 2
Acton 1
Amsterdam 1
Augusta 1
Beijing 1
Boardman 1
Brdo 1
Changsha 1
Clearwater 1
Cranford 1
Fasano 1
Geneva 1
Hanoi 1
Izmir 1
Los Angeles 1
Milan 1
Nagold 1
Norwalk 1
Redmond 1
Riga 1
Sandston 1
Seoul 1
Shenzhen 1
São Paulo 1
Washington 1
Wenzhou 1
Xian 1
Yardley 1
Šiauliai 1
Totale 254
Nome #
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 80
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 76
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 65
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 49
Non-Operative Management Versus Total Mesorectal Excision for Locally Advanced Rectal Cancer with Clinical Complete Response After Neoadjuvant Chemoradiotherapy: a GRADE Approach by the Rectal Cancer Guidelines Writing Group of the Italian Association of Medical Oncology (AIOM) 41
Activity and safety of cetuximab plus modified folfoxiri followed by maintenance with cetuximab or bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer a randomized phase 2 clinical trial 28
Management of Esophago-Gastric Junction Carcinoma: A Narrative Multidisciplinary Review 15
Management of Esophago-Gastric Junction Carcinoma: A Narrative Multidisciplinary Review 9
Role of radiomics in predicting lymph node metastasis in gastric cancer: a systematic review 8
Totale 371
Categoria #
all - tutte 2.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.181


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 5 2 0 2 0 2 0
2020/20214 0 0 0 1 0 0 1 0 0 1 1 0
2021/202276 0 14 5 5 5 2 2 12 5 5 6 15
2022/2023143 18 23 11 24 11 19 13 6 12 3 3 0
2023/202457 4 13 1 3 3 5 4 3 0 2 3 16
2024/202549 3 3 18 11 14 0 0 0 0 0 0 0
Totale 371